title: High dose rate afterloading 192 iridium prostate brachytherapy.
abstract: Since the evolution of prostate-specific antigen testing for prostate cancer, men have been diagnosed with earlier staged disease. Earlier staged cancer is amenable to local therapy. Over the last decade, new technology has evolved in the treatment of localized prostate cancer. High dose rate afterloading 192 Iridium prostate brachytherapy is a new innovative technique utilizing state of the art equipment and highly specialized computers to achieve precise treatment of prostate cancer with radiation. We present our initial experience with this innovative technique.
authors.affiliation: Department of Urology, East Jefferson General Hospital, Metairie, Louisiana, USA.
authors.forename: A Raoul
authors.initials: AR
authors.lastname: Bezou
authors.forename: Paul
authors.initials: P
authors.lastname: Monsour
authors.forename: Carl
authors.initials: C
authors.lastname: Buhler
authors.forename: Charles
authors.initials: C
authors.lastname: Sloan
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D019583:Dose Fractionation, Radiation; D006801:Humans; D007496:Iridium Radioisotopes / Q000008:administration & dosage*; D008297:Male; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging
chemical_list: D007496:Iridium Radioisotopes